Clinical trial
Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome
NCT01568593 is registered in ClinicalTrials.gov with Laboratoires Thea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome
- Lead sponsor
- Laboratoires Thea
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- March 31, 2013
- Enrollment
- 93 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.